LOGIN
Intramuscular Thiocolchicoside-Diclofenac vs. Diclofenac Monotherapy for Low Back Pain
August 2023
Intramuscular Thiocolchicoside-Diclofenac vs. Diclofenac Monotherapy for Low Back Pain
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
A randomized controlled trial evaluating the short-term efficacy of a single-administration intramuscular injection with the fixed combination of thiocolchicoside-diclofenac versus diclofenac monotherapy in patients with acute moderate-to-severe low back
BMC Musculoskelet Disord. 2023 Jun 10;24(1): 476.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and thirty-four patients with moderate-severe, acute low back pain were randomized to receive a single intramuscular injection of diclofenac-thiocolchicoside (n=68) or diclofenac only (n=66). The primary outcome of interest was the mean change in Visual Analog Scale (VAS) pain score from baseline to 3 hours. Secondary outcomes of interest include the percentage of patients showing a >3...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.